Adicet Bio, Inc.
ACET
$8.15
$0.040.43%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 137.59M | 158.53M | 103.10M | 124.96M | 150.44M |
| Total Receivables | 405.00K | 342.00K | 169.00K | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.07M | 2.05M | 3.23M | 2.78M | 3.12M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 140.07M | 160.93M | 106.49M | 127.74M | 153.56M |
|
|
|||||
| Total Current Assets | 140.07M | 160.93M | 106.49M | 127.74M | 153.56M |
| Net Property, Plant & Equipment | 26.36M | 28.48M | 30.97M | 32.10M | 34.49M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.95M | 2.95M | 3.01M | 3.13M | 3.22M |
| Total Assets | 169.38M | 192.36M | 140.48M | 162.97M | 191.27M |
|
|
|||||
| Total Accounts Payable | 2.93M | 4.74M | 4.29M | 3.29M | 4.40M |
| Total Accrued Expenses | 12.49M | 13.61M | 11.39M | 10.83M | 9.06M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.88M | 3.19M | 3.27M | 2.95M | 2.98M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 18.30M | 21.53M | 18.94M | 17.08M | 16.45M |
|
|
|||||
| Total Current Liabilities | 18.30M | 21.53M | 18.94M | 17.08M | 16.45M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 11.02M | 11.55M | 12.27M | 12.41M | 13.26M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 62.00K | 125.00K | 116.00K | 116.00K |
| Total Liabilities | 29.32M | 33.15M | 31.34M | 29.60M | 29.83M |
|
|
|||||
| Common Stock & APIC | 775.04M | 773.81M | 693.27M | 690.74M | 687.56M |
| Retained Earnings | -634.94M | -614.70M | -584.18M | -557.33M | -526.11M |
| Treasury Stock & Other | -37.00K | 102.00K | 56.00K | -41.00K | -9.00K |
| Total Common Equity | 140.07M | 159.21M | 109.14M | 133.37M | 161.45M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 140.07M | 159.21M | 109.14M | 133.37M | 161.45M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 140.07M | 159.21M | 109.14M | 133.37M | 161.45M |
|
|
|||||